News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,261 Results
Type
Article (13586)
Company Profile (110)
Press Release (247565)
Section
Business (87948)
Career Advice (462)
Deals (15324)
Drug Delivery (64)
Drug Development (36530)
Employer Resources (49)
FDA (6259)
Job Trends (6185)
News (150028)
Policy (14007)
Tag
Academia (435)
Alliances (23097)
Alzheimer's disease (352)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4325)
Biotechnology (44)
Breast cancer (42)
Cancer (315)
Career advice (405)
Cell therapy (44)
Clinical research (30402)
Collaboration (155)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (343)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31558)
Employer resources (43)
Events (36738)
Executive appointments (173)
FDA (6439)
Funding (108)
Gene therapy (59)
GLP-1 (292)
Government (1267)
Healthcare (3522)
Infectious disease (765)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5817)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9542)
Metabolic disorders (168)
Neuroscience (450)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (433)
Obesity (101)
Opinion (109)
Patents (53)
People (28460)
Pharmaceutical (64)
Phase I (7904)
Phase II (12857)
Phase III (11552)
Pipeline (183)
Policy (45)
Postmarket research (1399)
Preclinical (3165)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9821)
Research institute (563)
Resumes & cover letters (55)
Southern California (435)
Startups (1625)
United States (4280)
Vaccines (112)
Weight loss (78)
Date
Today (49)
Last 7 days (264)
Last 30 days (1264)
Last 365 days (12711)
2024 (11621)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19792)
Australia (2559)
California (1007)
Canada (602)
China (111)
Colorado (42)
Connecticut (42)
Europe (38779)
Florida (152)
Illinois (111)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (155)
Massachusetts (882)
Minnesota (56)
New Jersey (422)
New York (279)
North Carolina (278)
Northern California (433)
Pennsylvania (286)
South America (498)
Southern California (435)
Texas (138)
Virginia (41)
Washington State (71)
261,261 Results for "centessa pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
November 5, 2024
·
1 min read
Genetown
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
Nxera Pharma announced that it expects to receive $4.6 million in milestone payments from Centessa Pharmaceuticals pursuant to a license agreement regarding Nxera technology used to help design Centessa’s novel orexin receptor 2 agonist, ORX750.
May 30, 2024
·
2 min read
Genetown
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - May 21, 2024
Centessa Pharmaceuticals plc today announced that members of its management team will participate in the following investor conferences.
May 21, 2024
·
1 min read
Business
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
13 min read
Genetown
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Centessa Pharmaceuticals plc announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares, each representing one ordinary share.
April 23, 2024
·
3 min read
Genetown
Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
Centessa Pharmaceuticals plc announced the pricing of an underwritten public offering of 10,810,810 American Depositary Shares, each representing one ordinary share, at a price to the public of $9.25 per ADS.
April 23, 2024
·
4 min read
Business
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer
Centessa Pharmaceuticals plc announced that John Crowley CPA, has been appointed Chief Financial Officer, and Gregory Weinhoff MD MBA, former Chief Financial Officer, has been appointed to the newly created role of Chief Business Officer, effective June 10, 2024.
June 10, 2024
·
6 min read
Business
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported recent business highlights and financial results for the fourth quarter and full-year ended December 31, 2023.
March 28, 2024
·
14 min read
Press Releases
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
September 12, 2024
·
3 min read
Press Releases
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
September 13, 2024
·
4 min read
1 of 26,127
Next
